Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé Cboe Europe 16:45:58 08/09/2026			Varia. 5j.	Varia. 1 janv.
1 804,75 ^GBX	-1,78%		-3,77%	-1,29%

15:19	GSK lance une émission obligataire en dollars en six tranches pour financer l'acquisition de Nuvalent	MT
15:17	GSK lance une émission obligataire en dollars en six tranches pour financer l'acquisition de Nuvalent, selon Bloomberg	MT

Autres langues

15:19	GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition
15:17	GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports
10:09	Jefferies raises Autotrader and Rightmove
03/09	Global markets live: Apple, Microsoft, Tesla, Google, Uber…
03/09	Haleon Negotiates Better Shelf Placement at Walmart, Target
03/09	Wall Street im dreifachen Würgegriff
03/09	Afternoon Meeting: La triple amenaza que se cierne sobre Wall Street
03/09	Wall Street's Triple Squeeze
03/09	FTSE 100 edges higher; oil rises above USD97
03/09	WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit
03/09	Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
03/09	Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%
03/09	Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell
03/09	LondonMetric investments; Jet2 eyes Main Market move
03/09	Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
03/09	Morning Meeting: Trüber Auftakt in den Börsenherbst
03/09	HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%
03/09	A gloomy start to the autumn trading season
03/09	HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
03/09	Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
03/09	UK Stocks-Factors to watch on September 3
03/09	Hutchmed Grants GSK Global Rights to KRAS-EGFR Antibody Conjugate Cancer Therapy
03/09	HUTCHMED (China) signs exclusive licensing deal with GSK for investigational cancer drug
01/09	Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data
01/09	European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August